Daniel Winn, MD

Articles

November 8th 2019

CKD Quality Improvement Intervention With PCMH Integration: Health Plan Results

Joseph A. Vassalotti, MD Rachel DeVinney, MPH, CHES Stacey Lukasik, BA Sandra McNaney, BS Elizabeth Montgomery, BS Cindy Voss, MA Daniel Winn, MD

A scalable chronic kidney disease (CKD) quality improvement intervention demonstrated feasibility, decreased hospitalization, and reduced costs. These preliminary results support innovation in CKD by commercial health plans.

April 21st 2014

Physician Behavior Impact When Revenue Shifted From Drugs to Services

Bruce Feinberg, DO Scott Milligan, PhD Tim Olson, MBA Winston Wong, PharmD Daniel Winn, MD Ram Trehan, MD Jeffrey Scott, MD

Shifting physician revenue from drug sales to cognitive services for mature pathways providers did not affect practice behavior in this payer-sponsored Oncology Medical Home.

June 18th 2013

Third-Party Validation of Observed Savings From an Oncology Pathways Program

Bruce A. Feinberg, DO Scott Milligan, PhD Joseph Cooper, BS Winston Wong, PharmD Daniel Winn, MD Neil Schneider, ASA, MAAA Sheamus Parkes, FSA, MAAA Jeffrey Scott, MD